pGEX4T1-CBL-B Vector

The protein CBL is a ubiquitously expressed 982 amino acid E3 ubiquitin-protein ligase involved in cell signalling and protein ubiquitination.

Contributors

Inventor Institute
Danny Huang Cancer Research UK, Glasgow: The Beatson Institute
Cat. #: 153456
Tool sub type: pGEX4T1
Research Fields: Cancer;Cell signaling and signal transduction;Genetics
Target: CBL-B fragment encompassing the TKBD, LHR and RING domain: residues 36–427
Backbone size without insert: 4969
Bacterial resistance: Ampicillin
Alternate name: C-CBL, CBL-B, CBL-C, C-CBL2, FRA11B, NSLL, RNF55, Cbl proto-oncogene, Casitas B-lineage Lymphoma
Product description: Over 600 E3 ligases have been identified in mammals and most are part of the RING family of E3 ligases. The monomeric family of CBL RING E3 ligases (c-CBL, CBL-B and CBL-C) attenuate nonreceptor and receptor tyrosine kinase signalling through ubiquitination and direct the receptor tyrosine kinases for degradation through the endocytic or proteasomal pathways. Members of the CBL family share a highly conserved N terminus comprising of a tyrosine kinase binding domain, a linker helix region and a RING domain. The more variable C terminus possessing a proline-rich region and a string of terminal amino acids or 'extension'. Mutations in this gene have been implicated in several human cancers including acute myeloid leukaemia. The protein CBL is a ubiquitously expressed 982 amino acid E3 ubiquitin-protein ligase involved in cell signalling and protein ubiquitination.
Shipping conditions: Dry Ice
References:

Dou et al. 2013. Nat Struct Mol Biol. 20(8):982-6. PMID: 23851457.

Essentiality of a non-RING element in priming donor ubiquitin for catalysis by a monomeric E3.

Related Tools for Vectors

Cat. # Tool Name
151830 MultiDsk Vector Key Info View Tool
152046 pJEK1 Alpha-Synuclein Vector Key Info View Tool
152049 pJEK11 Beta-Synuclein Vector Key Info View Tool
152594 Norrin Mutant [R107E/R109E/R115L] Vector Key Info View Tool
153287 pCMV-iNOS Vector Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.